Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Marquardt

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Genes & Development|November 9, 2000
Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eyeR Ashery-Padan, T Marquardt, X Zhou, et al.
Hearing Research|May 13, 1999
Low-frequency modulation of the 2f1-f2 distortion product otoacoustic emissions in the human earG Scholz, A Hirschfelder, T Marquardt, et al.
European Journal of Pediatrics|May 20, 1998
The redox status of aminothiols as a clue to homocysteine-induced vascular damage?H G Koch, M Goebeler, T Marquardt, et al.
Molecular Biology of the Cell|November 15, 1997
Cholesterol-independent targeting of Golgi membrane proteins in insect cellsM M Rolls, M T Marquardt, M Kielian, et al.
European Journal of Cell Biology|March 1, 1995
Carbohydrate-deficient glycoprotein syndrome (CDGS)--glycosylation, folding and intracellular transport of newly synthesized glycoproteinsT Marquardt, K Ullrich, P Zimmer, et al.
Pest Management Science|July 23, 2013
The effect of nitrogen rate on transgenic corn Cry3Bb1 protein expressionPaul T Marquardt, Christian H Krupke, James J Camberato, et al.
Nature Genetics|April 28, 2001
Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiencyT Lübke, T Marquardt, A Etzioni, et al.
Cell|April 13, 2001
Pax6 is required for the multipotent state of retinal progenitor cellsT Marquardt, R Ashery-Padan, N Andrejewski, et al.
Public Health Action|March 29, 2021
Adverse events using shorter MDR-TB regimens: outcomes from Port Moresby, Papua New GuineaC Y Mason, A Prieto, H Bogati, et al.
Blood|December 10, 1999
Correction of leukocyte adhesion deficiency type II with oral fucoseT Marquardt, K Lühn, G Srikrishna, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Genes & Development|November 9, 2000
Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eyeR Ashery-Padan, T Marquardt, X Zhou, et al.
Hearing Research|May 13, 1999
Low-frequency modulation of the 2f1-f2 distortion product otoacoustic emissions in the human earG Scholz, A Hirschfelder, T Marquardt, et al.
European Journal of Pediatrics|May 20, 1998
The redox status of aminothiols as a clue to homocysteine-induced vascular damage?H G Koch, M Goebeler, T Marquardt, et al.
Molecular Biology of the Cell|November 15, 1997
Cholesterol-independent targeting of Golgi membrane proteins in insect cellsM M Rolls, M T Marquardt, M Kielian, et al.
European Journal of Cell Biology|March 1, 1995
Carbohydrate-deficient glycoprotein syndrome (CDGS)--glycosylation, folding and intracellular transport of newly synthesized glycoproteinsT Marquardt, K Ullrich, P Zimmer, et al.
Pest Management Science|July 23, 2013
The effect of nitrogen rate on transgenic corn Cry3Bb1 protein expressionPaul T Marquardt, Christian H Krupke, James J Camberato, et al.
Nature Genetics|April 28, 2001
Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiencyT Lübke, T Marquardt, A Etzioni, et al.
Cell|April 13, 2001
Pax6 is required for the multipotent state of retinal progenitor cellsT Marquardt, R Ashery-Padan, N Andrejewski, et al.
Public Health Action|March 29, 2021
Adverse events using shorter MDR-TB regimens: outcomes from Port Moresby, Papua New GuineaC Y Mason, A Prieto, H Bogati, et al.
Blood|December 10, 1999
Correction of leukocyte adhesion deficiency type II with oral fucoseT Marquardt, K Lühn, G Srikrishna, et al.
Pageof 6